Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9604
-0.0496 (-4.91%)
At close: Aug 20, 2026, 4:00 PM EDT
0.9991
+0.0387 (4.03%)
After-hours: Aug 20, 2026, 5:48 PM EDT
Lucid Diagnostics Revenue
Lucid Diagnostics had revenue of $1.47M in the quarter ending June 30, 2026, with 26.74% growth. This brings the company's revenue in the last twelve months to $5.45M, up 24.89% year-over-year. In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth.
Revenue (ttm)
$5.45M
Revenue Growth
+24.89%
P/S Ratio
33.71
Revenue / Employee
$66,402
Employees
82
Market Cap
183.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.71M | 360.00K | 8.28% |
| Dec 31, 2024 | 4.35M | 1.92M | 79.00% |
| Dec 31, 2023 | 2.43M | 2.05M | 544.03% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 354.30M |
| Neuronetics | 155.10M |
| Quanterix | 153.41M |
| InfuSystem Holdings | 143.34M |
| RxSight | 127.58M |
| Owlet | 114.41M |
| Standard BioTools | 84.60M |
| Apyx Medical | 58.42M |
LUCD News
- 2 days ago - Lucid Diagnostics Slides: Corporate presentation - Filings
- 3 days ago - Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c) - TheFly
- 6 days ago - PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire
- 7 days ago - Lucid Diagnostics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Lucid Diagnostics Quarterly report: Q2 2026 - Filings
- 7 days ago - Lucid Diagnostics Earnings release: Q2 2026 - Filings
- 7 days ago - Lucid Diagnostics Slides: Q2 2026 - Filings
- 7 days ago - Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results - PRNewsWire